ProQR Therapeutics

PRQR

Market cap $295M

Overview Fund Trends Analyst Outlook Journalist POV

2.80 USD

+0.09

3.32%

At close Updated Oct 16, 4:00 PM EDT

Pre-market

After hours

3.20

+0.40

14.29%

1 day

3.32%

5 days

11.55%

1 month

40.7%

3 months

19.15%

6 months

145.61%

Year to date

2.19%

1 year

-30.35%

5 years

-36.51%

10 years

-79.04%

About: ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Employees: 166

Healthcare Biotechnology